1. Home
  2. SMBK vs WVE Comparison

SMBK vs WVE Comparison

Compare SMBK & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SmartFinancial Inc.

SMBK

SmartFinancial Inc.

HOLD

Current Price

$51.04

Market Cap

887.9M

Sector

Finance

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$5.35

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMBK
WVE
Founded
N/A
2012
Country
United States
Singapore
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
887.9M
1.0B
IPO Year
2000
2015

Fundamental Metrics

Financial Performance
Metric
SMBK
WVE
Price
$51.04
$5.35
Analyst Decision
Buy
Strong Buy
Analyst Count
3
16
Target Price
$43.17
$29.81
AVG Volume (30 Days)
110.8K
3.1M
Earning Date
04-20-2026
04-28-2026
Dividend Yield
0.77%
N/A
EPS Growth
39.25
N/A
EPS
1.77
N/A
Revenue
N/A
$3,704,000.00
Revenue This Year
$17.59
N/A
Revenue Next Year
$10.30
$85.67
P/E Ratio
$28.79
N/A
Revenue Growth
N/A
149.43
52 Week Low
$33.01
$5.01
52 Week High
$54.14
$21.73

Technical Indicators

Market Signals
Indicator
SMBK
WVE
Relative Strength Index (RSI) 51.63 44.16
Support Level $50.93 $5.02
Resistance Level $53.71 $6.39
Average True Range (ATR) 1.16 0.34
MACD -0.42 -0.02
Stochastic Oscillator 27.14 23.93

Price Performance

Historical Comparison
SMBK
WVE

About SMBK SmartFinancial Inc.

SmartFinancial Inc operates as a bank holding company for SmartBank. It offers various banking and financial services to individuals and corporate customers. The principal business of the Bank consists of attracting deposits from the general public and investing those funds, together with funds generated from operations and from principal and interest payments on loans, mainly in commercial loans, commercial and residential real estate loans, consumer loans, and residential and commercial construction loans. The primary source of revenue is interest income from earning assets, namely loans and securities.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: